{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:26:00Z","timestamp":1768512360193,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of this study was to assess the socio-economic burden on families of children diagnosed with inflammatory bowel diseases (IBD), particularly ulcerative colitis (UC), and Crohn\u2019s disease (CD). The study was conducted at the 2nd Clinic of Paediatrics, Gastroenterology and Nutrition of Wroclaw Medical University. Anonymous questionnaires were completed by parents of paediatric IBD patients. The survey collected demographic, socio-economic, and treatment-related data. The study identified both material and non-material costs associated with IBD care. These included frequent private medical visits, medication, diet modifications, and transportation. Average monthly travel expenses were PLN 215.9 for UC and PLN 302.3 for CD (PLN\u2009=\u2009Polish zloty, 1 PLN\u2009=\u20090.25 euro). Limited access to paediatric gastroenterologists, especially in remote areas, led many families to seek private care, with associated monthly costs averaging PLN 312.3 for UC and PLN 513.3 for CD. Additionally, parents reported frequent work absences due to caregiving responsibilities, further impacting income and quality of life.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    :\u00a0Childhood IBD imposes a considerable financial and psychosocial burden on families. The findings underscore the need for improved access to public healthcare services and financial support mechanisms to reduce the strain on affected families.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What Is Known:<\/jats:bold>\n                              <jats:italic>\u2022 Families of children with IBD (ulcerative colitis, Crohn\u2019s disease) face significant costs related to medical care and lifestyle changes.<\/jats:italic>\n                              <jats:italic>\u2022 Limited access to specialised paediatric gastroenterologists and frequent absences from work add to the overall family burden.<\/jats:italic>\n                              <jats:bold>What Is New:<\/jats:bold>\n                              <jats:italic>\u2022 This study quantifies the monthly out-of-pocket travel and private care costs for paediatric IBD in Poland (PLN 215.9\u2013513.3), previously rarely documented.<\/jats:italic>\n                              <jats:italic>\u2022 The findings highlight significant non-material impacts, such as caregiver work absences, further reducing family quality of life.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06639-y","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T06:01:54Z","timestamp":1763877714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Socioeconomic costs incurred by parents of children with inflammatory bowel diseases"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5975-0354","authenticated-orcid":false,"given":"Piotr","family":"Marczy\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwiusz","family":"Kontek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Akutko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Pytrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"issue":"1","key":"6639_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ, Li YY (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20(1):91. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"issue":"1","key":"6639_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s13104-017-2814-3","volume":"10","author":"E Flood","year":"2017","unstructured":"Flood E, Silberg DG, Romero B, Beusterien K, Erder MH, Cuffari C (2017) Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings. BMC Res Notes 10(1):491. https:\/\/doi.org\/10.1186\/s13104-017-2814-3","journal-title":"BMC Res Notes"},{"key":"6639_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2083","volume":"357","author":"SB Oliveira","year":"2017","unstructured":"Oliveira SB, Monteiro IM (2017) Diagnosis and management of inflammatory bowel disease in children. BMJ 357:j2083. https:\/\/doi.org\/10.1136\/bmj.j2083","journal-title":"BMJ"},{"key":"6639_CR4","doi-asserted-by":"publisher","unstructured":"Clearfield HR (2008) How does IBD affect quality of life? Inflammatory Bowel Diseases 14(suppl_2), S45\u2013S46. https:\/\/doi.org\/10.1002\/ibd.20556","DOI":"10.1002\/ibd.20556"},{"issue":"4","key":"6639_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12(4):205\u2013217. https:\/\/doi.org\/10.1038\/nrgastro.2015.34","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"6639_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho G-T, Satsangi J, Bloom S, IBD Section of the British Society of Gastroenterology","year":"2011","unstructured":"Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho G-T, Satsangi J, Bloom S, IBD Section of the British Society of Gastroenterology (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60(5):571\u2013607. https:\/\/doi.org\/10.1136\/gut.2010.224154","journal-title":"Gut"},{"key":"6639_CR7","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/ajg.2011.58","volume":"106","author":"NJ Talley","year":"2011","unstructured":"Talley NJ, Abreu MT, Achkar J-P, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P (2011) An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 106:S2. https:\/\/doi.org\/10.1038\/ajg.2011.58","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"6639_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","volume":"63","author":"AB Pithadia","year":"2011","unstructured":"Pithadia AB, Jain S (2011) Treatment of inflammatory bowel disease (IBD). Pharmacol Rep 63(3):629\u2013642. https:\/\/doi.org\/10.1016\/S1734-1140(11)70575-8","journal-title":"Pharmacol Rep"},{"key":"6639_CR9","unstructured":"Ministry of Inrastracture of the Republic of Poland (2022) Rozporz\u0105dzenie Ministra Infrastruktury z dnia 22 grudnia 2022 r. https:\/\/isap.sejm.gov.pl\/isap.nsf\/download.xsp\/WDU20230000005\/O\/D20230005.pdf"},{"issue":"17","key":"6639_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173994","volume":"10","author":"E Krzesiek","year":"2021","unstructured":"Krzesiek E, Kofla-Dlubacz A, Akutko K, Stawarski A (2021) The incidence of inflammatory bowel disease in the paediatric population in the District of Lower Silesia, Poland. J Clin Med 10(17):3994. https:\/\/doi.org\/10.3390\/jcm10173994","journal-title":"J Clin Med"},{"key":"6639_CR11","unstructured":"The Act of 26 June 1974 \u2013 the Labour Code (consolidated text: Journal of Laws of 2025, item 277, as amended)."},{"key":"6639_CR12","unstructured":"Ustawa z dnia 25 czerwca 1999 r. o \u015bwiadczeniach pieni\u0119\u017cnych z ubezpieczenia spo\u0142ecznego w razie choroby i macierzy\u0144stwa (tekst jednolity: Dz.U. z 2025 r. poz. 501 ze zm.)"},{"issue":"1","key":"6639_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3141\/2265-22","volume":"2265","author":"J Mattson","year":"2011","unstructured":"Mattson J (2011) Transportation, distance, and health care utilization for older adults in rural and small urban areas. Transp Res Rec 2265(1):192\u2013199. https:\/\/doi.org\/10.3141\/2265-22","journal-title":"Transp Res Rec"},{"issue":"9","key":"6639_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1200\/OP.22.00122","volume":"18","author":"AN Wercholuk","year":"2022","unstructured":"Wercholuk AN, Parikh AA, Snyder RA (2022) The road less traveled: transportation barriers to cancer care delivery in the rural patient population. JCO Oncol Pract 18(9):652\u2013662. https:\/\/doi.org\/10.1200\/OP.22.00122","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"6639_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stemcr.2024.02.008","volume":"19","author":"M Obi","year":"2024","unstructured":"Obi M, Adams A, Vandenbossche A, Otero Pineiro A, Lightner AL (2024) Patient engagement and satisfaction with early phase cell therapy clinical trials at a tertiary inflammatory bowel disease center. Stem Cell Rep 19(4):435\u2013442. https:\/\/doi.org\/10.1016\/j.stemcr.2024.02.008","journal-title":"Stem Cell Rep"},{"issue":"2","key":"6639_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ibd\/izz120","volume":"26","author":"W El-Matary","year":"2020","unstructured":"El-Matary W, Kuenzig ME, Singh H, Okoli G, Moghareh M, Kumar H, L\u00ea M-L, Benchimol EI (2020) Dis-ease-associated costs in children with inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 26(2):206\u2013215. https:\/\/doi.org\/10.1093\/ibd\/izz120","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"6639_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2006.05.052","volume":"131","author":"Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O\u2019morain C, Moum B, European Collaborative Study on Inflammatory Bowel Disease","year":"2006","unstructured":"Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O\u2019morain C, Moum B, European Collaborative Study on Inflammatory Bowel Disease (2006) Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 131(3):719\u2013728. https:\/\/doi.org\/10.1053\/j.gastro.2006.05.052","journal-title":"Gastroenterology"},{"issue":"7","key":"6639_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/apt.17675","volume":"58","author":"\u00c5H Everhov","year":"2023","unstructured":"Everhov \u00c5H, S\u00f6derling J, Befrits G, Khalili H, Br\u00f6ms G, Neovius M, Askling J, Halfvarson J, Ludvigsson JF, Ol\u00e9n O (2023) Increasing healthcare costs in inflammatory bowel disease 2007\u20132020 in Sweden. Aliment Pharmacol Ther 58(7):692\u2013703. https:\/\/doi.org\/10.1111\/apt.17675","journal-title":"Aliment Pharmacol Ther"},{"key":"6639_CR19","doi-asserted-by":"publisher","unstructured":"Baig MMA, Fatima S, Fatima M, Siddiqui S, Ali SA, Ilyas MN (2017) Prescription pattern and cost of illness (COI) of inflammatory bowel disease (IBD) in a tertiary care hospital.\u00a0Int J Pharm Pharm Sci\u00a044\u201347. https:\/\/doi.org\/10.22159\/ijpps.2017v9i1.14248","DOI":"10.22159\/ijpps.2017v9i1.14248"},{"key":"6639_CR20","unstructured":"Park KT, Sin AT, Damman JL, Ziring DA, Gleghorn EE, Garcia-Careaga MG, Ziring DA, Gugig \u2016, Roberto R, Hunter AK, Burgis JC, Bass DM (2015) Out-of-pocket cost burden in pediatric inflammatory bowel disease: a cross-sectional cohort analysis.\u00a0Inflamm Bowel Dis\u00a021. http:\/\/healthpolicy.fsi.stanford.edu\/publication\/out-pocket-cost-burden-pediatric-inflammatory-bowel-disease-cross-sectional-cohort"},{"issue":"2","key":"6639_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5114\/aoms.2016.59254","volume":"12","author":"P Kawalec","year":"2016","unstructured":"Kawalec P (2016) Indirect costs of inflammatory bowel diseases: Crohn\u2019s disease and ulcerative colitis. A systematic review. Arch Med Sci AMS 12(2):295\u2013302. https:\/\/doi.org\/10.5114\/aoms.2016.59254","journal-title":"Arch Med Sci AMS"},{"issue":"9","key":"6639_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","volume":"15","author":"M Zhao","year":"2021","unstructured":"Zhao M, G\u00f6nczi L, Lakatos PL, Burisch J (2021) The burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis 15(9):1573\u20131587. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab029","journal-title":"J Crohns Colitis"},{"issue":"2","key":"6639_CR23","first-page":"97","volume":"13","author":"T Pytrus","year":"2011","unstructured":"Pytrus T (2011) Direct costs of outpatient care in pediatric inflammatory bowel diseases. Pediatr Wspolczesna 13(2):97\u2013101","journal-title":"Pediatr Wspolczesna"},{"issue":"7","key":"6639_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10198-022-01536-9","volume":"24","author":"P Holko","year":"2023","unstructured":"Holko P, Kawalec P, Sajak-Szczerba M, Avedano L, Mossakowska M (2023) Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries. Eur J Health Econ 24(7):1073\u20131083. https:\/\/doi.org\/10.1007\/s10198-022-01536-9","journal-title":"Eur J Health Econ"},{"issue":"22","key":"6639_CR25","first-page":"4742","volume":"20","author":"S Bibb\u00f2","year":"2016","unstructured":"Bibb\u00f2 S, Ianiro G, Giorgio V, Scaldaferri F, Masucci L, Gasbarrini A, Cammarota G (2016) The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci 20(22):4742\u20134749","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6639_CR26","doi-asserted-by":"publisher","unstructured":"Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM (2022) The Role of Diet and Gut Microbiota in Regulat-ing Gastrointestinal and Inflammatory Disease.\u00a0Front Immunol\u00a013. https:\/\/doi.org\/10.3389\/fimmu.2022.866059","DOI":"10.3389\/fimmu.2022.866059"},{"issue":"3","key":"6639_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cgh.2019.11.054","volume":"19","author":"AN Sasson","year":"2021","unstructured":"Sasson AN, Ananthakrishnan AN, Raman M (2021) Diet in treatment of inflammatory bowel diseases. Clin Gastroenterol Hepatol 19(3):425\u2013435.e3. https:\/\/doi.org\/10.1016\/j.cgh.2019.11.054","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"6639_CR28","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1017\/S1368980013002115","volume":"17","author":"N Shivappa","year":"2014","unstructured":"Shivappa N, Steck SE, Hurley TG, Hussey JR, H\u00e9bert JR (2014) Designing and developing a litera-ture-derived, population-based dietary inflammatory index. Public Health Nutr 17(8):1689\u20131696. https:\/\/doi.org\/10.1017\/S1368980013002115","journal-title":"Public Health Nutr"},{"key":"6639_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59020329","author":"M Nitescu","year":"2023","unstructured":"Nitescu M, Istratescu D, Preda CM, Manuc TE, Louis E, Manuc M, Stroie T, Catrinoiu M, Tieranu CG, Badea LE, Tugui L, Andrei A, Diculescu MM (2023) Role of an exclusion diet (reduced disaccharides, satu-rated fats, emulsifiers, red and ultraprocessed meats) in maintaining the remission of chronic inflammatory bowel diseases in adults. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59020329","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"6639_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1089\/jmf.2018.0206","volume":"22","author":"A Pituch-Zdanowska","year":"2019","unstructured":"Pituch-Zdanowska A, Kowalska-Duplaga K, Jarocka-Cyrta E, Stawicka A, Dziekiewicz M, Banaszkiewicz A (2019) Dietary beliefs and behaviors among parents of children with inflammatory bowel disease. J Med Food 22(8):817\u2013822. https:\/\/doi.org\/10.1089\/jmf.2018.0206","journal-title":"J Med Food"},{"issue":"10","key":"6639_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/ibd\/izad255","volume":"30","author":"R Sigall Boneh","year":"2024","unstructured":"Sigall Boneh R, Westoby C, Oseran I, Sarbagili-Shabat C, Albenberg LG, Lionetti P, Manuel Navas-L\u00f3pez V, Mart\u00edn-de-Carpi J, Yanai H, Maharshak N, Van Limbergen J, Wine E (2024) The Crohn\u2019s disease exclu-sion diet: a comprehensive review of evidence, implementation strategies, practical guidance, and future directions. Inflamm Bowel Dis 30(10):1888\u20131902. https:\/\/doi.org\/10.1093\/ibd\/izad255","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"6639_CR32","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.jval.2023.09.851","volume":"26","author":"SA Wooller","year":"2023","unstructured":"Wooller SA, Patel M, Sharma P, Capobianco ME, Longo R (2023) EE586 comparison of enteral nutritional therapy to induce and maintain remission in paediatric patients with mild-to-moderate Crohn\u2019s disease: a cost-effectiveness analysis in the UK. Value Health 26(12):S165\u2013S166. https:\/\/doi.org\/10.1016\/j.jval.2023.09.851","journal-title":"Value Health"},{"issue":"1","key":"6639_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2468-1253(21)00299-5","volume":"7","author":"H Yanai","year":"2022","unstructured":"Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N (2022) The Crohn\u2019s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn\u2019s disease (CDED-AD): an open-label, pilot, randomised trial. The Lancet Gastroentero-logy & Hepatology 7(1):49\u201359. https:\/\/doi.org\/10.1016\/S2468-1253(21)00299-5","journal-title":"The Lancet Gastroentero-logy & Hepatology"},{"issue":"2","key":"6639_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.13075\/ijomeh.1896.01486","volume":"33","author":"WS Zgliczy\u0144ski","year":"2020","unstructured":"Zgliczy\u0144ski WS, Jankowski M, Rostkowska O, Sytnik-Czetwerty\u0144ski J, \u015ali\u017c D, Karczemna A, Pinkas J (2020) Public and private health care services in the opinion of physicians in Poland. Int J Occup Med Environ Health 33(2):195\u2013214. https:\/\/doi.org\/10.13075\/ijomeh.1896.01486","journal-title":"Int J Occup Med Environ Health"},{"key":"6639_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192416733","author":"D Smar\u017cewska","year":"2022","unstructured":"Smar\u017cewska D, Wereda WS, Jo\u0144czyk JA (2022) Assessment of the health care system in Poland and other OECD countries using the Hellwig method. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph192416733","journal-title":"Int J Environ Res Public Health"},{"key":"6639_CR36","doi-asserted-by":"publisher","unstructured":"Nationwide data on epidemiology of inflammatory bowel disease in Poland between 2009 and 2020. (n.d.). https:\/\/doi.org\/10.20452\/pamw.16194","DOI":"10.20452\/pamw.16194"},{"issue":"1","key":"6639_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA (2020) The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & colitis foundation. Inflamm Bowel Dis 26(1):1\u201310. https:\/\/doi.org\/10.1093\/ibd\/izz104","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"6639_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00019053-200523010-00003","volume":"23","author":"E Beghi","year":"2005","unstructured":"Beghi E, Frigeni B, Beghi M, De Compadri P, Garattini L (2005) A review of the costs of managing childhood epilepsy. Pharmacoeconomics 23(1):27\u201345. https:\/\/doi.org\/10.2165\/00019053-200523010-00003","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"6639_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/ibd\/izz183","volume":"26","author":"AW Fondell","year":"2020","unstructured":"Fondell AW, Mosha MH, Frank CR, Brangi JM, Hyams JS (2020) Health care cost for children newly di-agnosed with inflammatory bowel disease. Inflamm Bowel Dis 26(4):635\u2013640. https:\/\/doi.org\/10.1093\/ibd\/izz183","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"6639_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ppul.1095","volume":"32","author":"WJ Ungar","year":"2001","unstructured":"Ungar WJ, Coyte PC (2001) Prospective study of the patient-level cost of asthma care in children. Pediatric Pulmo-nology 32(2):101\u2013108. https:\/\/doi.org\/10.1002\/ppul.1095","journal-title":"Pediatric Pulmo-nology"},{"issue":"1","key":"6639_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/j.1536-4801.1993.tb10917.x","volume":"17","author":"AG Thomas","year":"1993","unstructured":"Thomas AG, Taylor F, Miller V (1993) Dietary intake and nutritional treatment in childhood Crohn\u2019s disease. J Pediatr Gastroenterol Nutr 17(1):75\u201381. https:\/\/doi.org\/10.1002\/j.1536-4801.1993.tb10917.x","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9\u201310","key":"6639_CR42","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/jocn.16446","volume":"32","author":"P Thapwong","year":"2023","unstructured":"Thapwong P, Norton C, Rowland E, Farah N, Czuber-Dochan W (2023) A systematic review of the impact of inflammatory bowel disease (IBD) on family members. J Clin Nurs 32(9\u201310):2228\u20132238. https:\/\/doi.org\/10.1111\/jocn.16446","journal-title":"J Clin Nurs"},{"key":"6639_CR43","doi-asserted-by":"publisher","unstructured":"Cai Z, Wang S, Li J (2021) Treatment of inflammatory bowel disease: a comprehensive review.\u00a0Front Med 8. https:\/\/doi.org\/10.3389\/fmed.2021.765474","DOI":"10.3389\/fmed.2021.765474"},{"issue":"4","key":"6639_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cch.12446","volume":"43","author":"J Luijkx","year":"2017","unstructured":"Luijkx J, van der Putten AaJ, Vlaskamp C (2017) Time use of parents raising children with severe or profound intellectual and multiple disabilities. Child Care Health Dev 43(4):518\u2013526. https:\/\/doi.org\/10.1111\/cch.12446","journal-title":"Child Care Health Dev"},{"issue":"1","key":"6639_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1477-7525-6-91","volume":"6","author":"MA Arafa","year":"2008","unstructured":"Arafa MA, Zaher SR, El-Dowaty AA, Moneeb DE (2008) Quality of life among parents of children with heart disease. Health Qual Life Outcomes 6(1):91. https:\/\/doi.org\/10.1186\/1477-7525-6-91","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"6639_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2340\/00015555-2633","volume":"97","author":"J Marciniak","year":"2017","unstructured":"Marciniak J, Reich A, Szepietowski JC (2017) Quality of life of parents of children with atopic dermatitis. Acta Derm Venereol 97(6):711\u2013714. https:\/\/doi.org\/10.2340\/00015555-2633","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"6639_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/archdischild-2019-317765","volume":"105","author":"C Barnes","year":"2020","unstructured":"Barnes C, Ashton JJ, Borca F, Cullen M, Walker DM, Beattie RM (2020) Children and young people with in-flammatory bowel disease attend less school than their healthy peers. Arch Dis Child 105(7):671\u2013676. https:\/\/doi.org\/10.1136\/archdischild-2019-317765","journal-title":"Arch Dis Child"},{"issue":"3","key":"6639_CR48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5217\/ir.2017.15.3.338","volume":"15","author":"YS Kim","year":"2017","unstructured":"Kim YS, Jung SA, Lee KM, Park SJ, Kim TO, Choi CH, Kim HG, Moon W, Moon CM, Song HK, Na S-Y, Yang S-K, Korean Association for the Study of Intestinal Diseases (KASID) (2017) Impact of inflam-matory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Dis-eases. Intest Res 15(3):338\u2013344. https:\/\/doi.org\/10.5217\/ir.2017.15.3.338","journal-title":"Intest Res"},{"issue":"5","key":"6639_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/01.MIB.0000218762.61217.4a","volume":"12","author":"T Bernklev","year":"2006","unstructured":"Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B (2006) Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with in-flammatory bowel disease. Inflamm Bowel Dis 12(5):402\u2013412. https:\/\/doi.org\/10.1097\/01.MIB.0000218762.61217.4a","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"6639_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/archdischild-2023-325668","volume":"109","author":"JJ Ashton","year":"2024","unstructured":"Ashton JJ, Beattie RM (2024) Inflammatory bowel disease: recent developments. Arch Dis Child 109(5):370\u2013376. https:\/\/doi.org\/10.1136\/archdischild-2023-325668","journal-title":"Arch Dis Child"},{"issue":"1","key":"6639_CR51","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058037","volume":"151","author":"M Bouhuys","year":"2022","unstructured":"Bouhuys M, Lexmond WS, van Rheenen PF (2022) Pediatric Inflammatory Bowel Disease. Pediatrics 151(1):e2022058037. https:\/\/doi.org\/10.1542\/peds.2022-058037","journal-title":"Pediatrics"},{"issue":"8","key":"6639_CR52","first-page":"400","volume":"16","author":"J Breton","year":"2020","unstructured":"Breton J, Kastl A, Conrad MA, Baldassano RN (2020) Positioning biologic therapies in the management of pediatric inflammatory bowel disease. Gastroenterology Hepatol 16(8):400","journal-title":"Gastroenterology Hepatol"},{"issue":"2","key":"6639_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ecco-jcc\/jjv233","volume":"10","author":"J Sieczkowska","year":"2016","unstructured":"Sieczkowska J, Jarz\u0119bicka D, Banaszkiewicz A, Plocek A, Gawronska A, Toporowska-Kowalska E, Oracz G, Meglicka M, Kierkus J (2016) Switching between infliximab originator and biosimilar in paediatric patients with inflammatory bowel disease. Preliminary observations. J Crohns Colitis 10(2):127\u2013132. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv233","journal-title":"J Crohns Colitis"},{"issue":"30","key":"6639_CR54","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.3748\/wjg.v23.i30.5469","volume":"23","author":"G Guariso","year":"2017","unstructured":"Guariso G, Gasparetto M (2017) Treating children with inflammatory bowel disease: current and new perspectives. World J Gastroenterol 23(30):5469. https:\/\/doi.org\/10.3748\/wjg.v23.i30.5469","journal-title":"World J Gastroenterol"},{"key":"6639_CR55","unstructured":"Cost of Pediatric IBD Care: how to best invest in our children. Inflammatory Bowel Diseases.\u00a0 Oxford Academic (n.d.) Retrieved 20 November 2024 from.\u00a0https:\/\/academic.oup.com\/ibdjournal\/article\/26\/4\/641\/5554165"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06639-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:42:36Z","timestamp":1768459356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06639-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6639"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06639-y","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Wroclaw Medical University No. KB 508\/2023N, approved on 21 December 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All study participants gave informed and voluntary consent to participate in the study. They were informed of its anonymity and voluntariness.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"782"}}